Target Name: MS4A15
NCBI ID: G219995
Review Report on MS4A15 Target / Biomarker Content of Review Report on MS4A15 Target / Biomarker
MS4A15
Other Name(s): membrane spanning 4-domains A15 | Membrane spanning 4-domains A15, transcript variant 1 | Membrane-spanning 4-domains subfamily A member 15 | M4A15_HUMAN | Membrane-spanning 4-domains subfamily A member 15 (isoform 1) | membrane-spanning 4-domains subfamily A member 15 | MS4A15 variant 1

MS4A15: A Potential Drug Target Or Biomarker

MS4A15, also known as membrane spanning 4-domains A15, is a protein that is expressed in various tissues throughout the body. It plays a crucial role in the structure and function of various biological systems, including the nervous system, endocrine system, and immune system. Due to its unique structure and the various functions it is involved in, MS4A15 has potential as a drug target or biomarker.

The protein MS4A15 is composed of four transmembrane domains, which are responsible for its unique structure and function. The first domain is a cytoplasmic domain that is involved in the protein's localization and interactions within the cell. The second domain is a transmembrane domain that is responsible for the protein's proper functioning. The third domain is an extracellular domain that is involved in the protein's interactions with other proteins and the extracellular environment. The fourth domain is also a transmembrane domain that is responsible for the protein's interactions with other proteins and the extracellular environment.

MS4A15 is involved in various physiological processes that are essential for the proper functioning of the body. One of its most important functions is in the regulation of neural signaling. MS4A15 is known to play a role in the regulation of neurotransmitter release from neurons, which is critical for the transmission of signals in the nervous system.

In addition to its role in neural signaling, MS4A15 is also involved in the regulation of other physiological processes that are essential for the proper functioning of the body. For example, it is involved in the regulation of ion channels, which are responsible for the proper flow of electrical signals through the cell membrane. It is also involved in the regulation of protein kinase signaling, which is essential for the proper functioning of many cellular processes.

MS4A15 has also been shown to play a role in the development and progression of various diseases. For example, studies have shown that high levels of MS4A15 are associated with an increased risk of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, high levels of MS4A15 have also been associated with an increased risk of certain cardiovascular diseases, such as myocardial infarction and stroke.

Due to its unique structure and the various functions it is involved in, MS4A15 has potential as a drug target or biomarker. Studies have shown that targeting MS4A15 with small molecules has the potential to treat various diseases, including neurodegenerative diseases and cardiovascular diseases. Additionally, understanding the molecular mechanisms that regulate MS4A15 may also provide insights into the development of new therapeutic approaches for these diseases.

In conclusion, MS4A15 is a protein that is involved in various physiological processes that are essential for the proper functioning of the body. Its unique structure and the various functions it is involved in make it a potential drug target or biomarker. Further research is needed to understand the full potential of MS4A15 and its potential as a therapeutic approach for various diseases.

Protein Name: Membrane Spanning 4-domains A15

Functions: May be involved in signal transduction as a component of a multimeric receptor complex

The "MS4A15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MS4A15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MS4A18 | MS4A2 | MS4A3 | MS4A4A | MS4A4E | MS4A5 | MS4A6A | MS4A6E | MS4A7 | MS4A8 | MSANTD1 | MSANTD2 | MSANTD3 | MSANTD4 | MSC | MSC-AS1 | MSGN1 | MSH2 | MSH3 | MSH4 | MSH5 | MSH5-SAPCD1 | MSH6 | MSI1 | MSI2 | MSL1 | MSL2 | MSL3 | MSL3P1 | MSLN | MSLNL | MSMB | MSMO1 | MSMP | MSN | MSNP1 | MSR1 | MSRA | MSRA-DT | MSRB1 | MSRB1P1 | MSRB2 | MSRB3 | MSRB3-AS1 | MSS51 | MST1 | MST1L | MST1P2 | MST1R | MSTN | MSTO1 | MSTO2P | MSX1 | MSX2 | MSX2P1 | MT1A | MT1B | MT1DP | MT1E | MT1F | MT1G | MT1H | MT1HL1 | MT1IP | MT1JP | MT1L | MT1M | MT1P1 | MT1P3 | MT1X | MT1XP1 | MT2A | MT3 | MT4 | MTA1 | MTA1-DT | MTA2 | MTA3 | MTAP | MTARC1 | MTARC2 | MTATP6P1 | MTATP8P1 | MTBP | MTCH1 | MTCH2 | MTCL1 | MTCO1P1 | MTCO1P12 | MTCO1P15 | MTCO2P33 | MTCO3P1 | MTCO3P12 | MTCP1 | MTDH | MTERF1 | MTERF2 | MTERF3 | MTERF4 | MTF1